Silver-coated (PorAg
Bone sarcoma
Endoprosthetic replacement
Infection
Silver coating
Journal
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie
ISSN: 1432-1068
Titre abrégé: Eur J Orthop Surg Traumatol
Pays: France
ID NLM: 9518037
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
24
04
2020
accepted:
13
05
2020
pubmed:
26
5
2020
medline:
19
8
2021
entrez:
26
5
2020
Statut:
ppublish
Résumé
We aim to evaluate the use of silver (PorAg In total, 68 patients were retrospectively evaluated. Median age was 30 years (range 14-83). In total, 29 patients were re-implanted with PorAg At 3-year follow-up, estimated reinfection rate in the silver group was slightly lower than in uncoated EPR (10.3% vs. 17.5%, p = 0.104). Among reinfected patients, only one out of three patients (33%) in the silver group required an amputation compared to 80% in the nonsilver group (p = 0.047). Our results show the efficacy of PorAg
Identifiants
pubmed: 32449080
doi: 10.1007/s00590-020-02705-3
pii: 10.1007/s00590-020-02705-3
doi:
Substances chimiques
Silver
3M4G523W1G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1345-1353Commentaires et corrections
Type : ErratumIn